Reskon Pharmaceutical Private Limited
About Reskon Pharmaceutical Private Limited
Data last updated:
Reskon Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC302433. Its GSTIN is 27AAICR6490A1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Brijabala Deenanath Shukla and Rupesh Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 40 Sunshine Commercial Complex Nallasopara (E), Thane, Maharashtra, India – 401209.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.22 Lakh, a growth of 71% compared to the previous year. For the same year it recorded a net profit of ₹31,256 (net margin 0.9%) and EBITDA of ₹61,656 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years and 34% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No. 40 Sunshine Commercial Complex Nallasopara (E), Thane, Maharashtra, India – 401209
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Reskon Pharmaceutical Private Limited
The main business activity of Reskon Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Reskon Pharmaceutical Private Limited FY 2024 filings available
Reskon Pharmaceutical Private Limited reported revenue of ₹33.22 Lakh (up 71% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Reskon Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 71% growth in the latest year. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reskon Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹61,656 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31,256 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reskon Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reskon Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Barophar Marketing Pvt Ltd | ₹33.37 Lakh (FY 2025) | •••• | •••• | -52.0% | •••• | Ernakulam, Kerala, India |
| Purecaps India Private Limited | ₹33.34 Lakh (FY 2025) | •••• | •••• | •••• | Panch Mahals, Gujarat, India | |
| Neha Speciality Chemicals Private Limited | ₹33.33 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Raipur, Chhattisgarh, India |
| Ventito Private Limited | ₹33.32 Lakh (FY 2025) | •••• | •••• | 119.0% | •••• | Gmc, Assam, India |
| Drati Pharmaceuticals Private Limited | ₹33.29 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Thane, Maharashtra, India |
| Reskon Pharmaceutical Private Limited this company | ₹33.22 Lakh (FY 2024) | •••• | •••• | 71.0% | •••• | Thane, Maharashtra, India |
| Cathartic Marketing (OPC) Private Limited | ₹33.21 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Ibmvitamins Pharma Private Limited | ₹33.17 Lakh (FY 2017) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Girgla Pharmaceuticals Private Limited | ₹33.09 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | New Delhi, Delhi, India |
| Bluestar Lifecare Private Limited | ₹33.08 Lakh (FY 2025) | •••• | •••• | 277.0% | •••• | Mumbai, Maharashtra, India |
| Charitra Pharmaceuticals Private Limited | ₹33.08 Lakh (FY 2023) | •••• | •••• | 25.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Reskon Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical Private Limited is audited by Sharma Surendra K & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sharma Surendra K & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brijabala Deenanath Shukla | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
| Rupesh Kumar Mishra | Director | 04 Nov 2023 | 2 Years 11 Months | Current |
Ownership and Shareholding of Reskon Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Reskon Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Reskon Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Abhishek Kumar Dubey ceased to be Director on 07 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Reskon Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Reskon Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reskon Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR6490A1ZB | Maharashtra | Active | 07 Jun 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reskon Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reskon Pharmaceutical Private Limited
Reskon Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 December 2017 (9+ years old) and is registered under CIN U51909MH2017PTC302433.
Reskon Pharmaceutical reported revenue of ₹33.22 Lakh for FY 2024 (up 71% YoY).
Reskon Pharmaceutical has 2 current directors:
- Brijabala Deenanath Shukla - Director
- Rupesh Kumar Mishra - Director
Reskon Pharmaceutical reported a net profit of ₹31,256 (net margin 0.9%) and EBITDA of ₹61,656 (EBITDA margin 1.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Reskon Pharmaceutical is 81% over three years and 34% over five years. In the latest year (FY 2024) revenue rose 71%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Reskon Pharmaceutical is 27AAICR6490A1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reskon Pharmaceutical is U51909MH2017PTC302433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reskon Pharmaceutical was incorporated on 04 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Reskon Pharmaceutical by revenue are Barophar Marketing Pvt Ltd, Purecaps India Private Limited, Neha Speciality Chemicals Private Limited, Ventito Private Limited, Drati Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Abhishek Kumar Dubey ceased to be Director on 07 Nov 2023. Rupesh Kumar Mishra was appointed as Director on 04 Nov 2023. Rupesh Kumar Mishra ceased to be Director on 30 Oct 2022. Reskon Pharmaceutical has 6 board changes on record in total.
The registered office of Reskon Pharmaceutical is at Shop No. 40 Sunshine Commercial Complex Nallasopara E, Thane, Maharashtra, India – 401209.